Topical enzyme-replacement therapy restores transglutaminase 1 activity and corrects architecture of transglutaminase-1-deficient skin grafts.
about
Review of the 94th Annual Meeting of the British Association of Dermatologists, Glasgow 2014.Mutations in SULT2B1 Cause Autosomal-Recessive Congenital Ichthyosis in Humans.Increased cutaneous absorption reflects impaired barrier function of reconstructed skin models mimicking keratinisation disorders.Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels.Inherited Nonsyndromic Ichthyoses: An Update on Pathophysiology, Diagnosis and Treatment.Ichthyoses: new insights unravel defects in skin barrier function resulting in diverse clinical and morphological phenotypes.
P2860
Topical enzyme-replacement therapy restores transglutaminase 1 activity and corrects architecture of transglutaminase-1-deficient skin grafts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Topical enzyme-replacement the ...... inase-1-deficient skin grafts.
@en
Topical enzyme-replacement the ...... inase-1-deficient skin grafts.
@nl
type
label
Topical enzyme-replacement the ...... inase-1-deficient skin grafts.
@en
Topical enzyme-replacement the ...... inase-1-deficient skin grafts.
@nl
prefLabel
Topical enzyme-replacement the ...... inase-1-deficient skin grafts.
@en
Topical enzyme-replacement the ...... inase-1-deficient skin grafts.
@nl
P2093
P2860
P1476
Topical enzyme-replacement the ...... minase-1-deficient skin grafts
@en
P2093
Blanca Duarte
Fernando Larcher
Heike Nikolenko
Heiko Traupe
Ingrid Hausser
Karin Aufenvenne
Marcela Del Rio
Margitta Dathe
P2860
P304
P356
10.1016/J.AJHG.2013.08.003
P407
P50
P577
2013-09-19T00:00:00Z